Genetic association and computational analysis of MTHFR gene polymorphisms rs1801131 and rs1801133 with breast cancer in the Bangladeshi population

被引:0
|
作者
Nazia Fairooz Alam [1 ]
Rubaiat Ahmed [2 ]
Zimam Mahmud [1 ]
Sonia Tamanna [1 ]
Md Akeruzzaman Shaon [1 ]
Md. Zakir Hossain Howlader [1 ]
机构
[1] University of Dhaka,Laboratory of Nutrition and Health Research, Department of Biochemistry and Molecular Biology
[2] National Institute of Biotechnology,Molecular Biotechnology Division
关键词
Methylenetetrahydrofolate reductase; Genetic polymorphisms; rs1801133; rs1801131; PCR-RFLP; Bangladeshi population;
D O I
10.1038/s41598-024-75656-y
中图分类号
学科分类号
摘要
Methylenetetrahydrofolate reductase (MTHFR) plays a crucial role in regulating one-carbon metabolism. Polymorphisms within the MTHFR gene have been found to increase the risk of breast cancer in different populations. In this study, we evaluated the association of polymorphisms of the MTHFR gene (rs1801133 and rs1801131) with the risk of breast cancer in the Bangladeshi population. This case‒control study included 202 breast cancer patients and 104 healthy controls. After the organic extraction of DNA, genotyping was performed via the PCR-RFLP method. Sanger sequencing was performed to validate the RFLP data. Statistical analyses were performed to evaluate the associations of the polymorphisms. Different computational tools were used to predict the structural and functional consequences of the SNPs. Our study revealed that the MTHFR gene polymorphism rs1801131 is associated with an increased risk of developing breast cancer (p < 0.001, OR = 3.85, 95% CI = 2.06–7.25 for the AC genotype and p < 0.001, OR = 7.82, 95% CI = 2.69–22.05 for the CC genotype). An association was also observed in the dominant model (AC + CC) (p < 0.001, OR = 4.19, 95% CI = 2.28–7.78). For rs1801131, premenopausal status was significantly associated with breast cancer risk (p < 0.001). For rs1801133, no significant association was found with breast cancer risk (p > 0.05, OR = 1.57, 95% CI = 0.90–2.74 for the CT genotype; p > 0.05, OR = 1.35, 95% CI = 0.36–4.92 for the TT genotype). Computational analyses predicted rs1801131 to be tolerated and rs1801133 to be deleterious. Structural analyses demonstrated no significant changes in protein structure but revealed alterations in neighboring interactions according to both bond distances and angles. In conclusion, rs1801131 but not rs1801133 is significantly associated with breast cancer risk in the Bangladeshi population. Moreover, in silico analyses demonstrated changes in the interaction pattern of polymorphic residues with adjacent amino acids.
引用
收藏
相关论文
共 50 条
  • [41] Lack of association of MTHFR rs1801133 polymorphism and CTCFL mutations with sperm methylation errors in infertile patients
    Camprubi, Cristina
    Pladevall, Marta
    Grossmann, Mark
    Garrido, Nicolas
    Pons, Maria C.
    Blanco, Joan
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2013, 30 (09) : 1125 - 1131
  • [42] MTHFR rs1801133 polymorphism and susceptibility to colorectal cancer in Iranian population: evidence of a case-control study and meta-analysis
    Haerian, Monir Sadat
    Haerian, Batoul Sadat
    Molanaei, Saadat
    Kosari, Farid
    Sabeti, Shahram
    Bidari-Zerehpoosh, Farahnaz
    Abdolali, Ebrahim
    Zali, Mohammad Reza
    PHARMACOGENOMICS, 2016, 17 (17) : 1957 - 1965
  • [43] Association between methylenetetrahydrofolate reductase gene rs1801131 A/C polymorphism and urinary tumors' susceptibility
    Xu, Shuaili
    Zuo, Li
    HEREDITAS, 2020, 157 (01)
  • [44] Association between methylenetetrahydrofolate reductase gene rs1801131 A/C polymorphism and urinary tumors’ susceptibility
    Shuaili Xu
    Li Zuo
    Hereditas, 157
  • [45] MTHFR C677T (rs1801133) genetic polymorphism is associated with development risk of essential hypertension in the Turkish population
    Zafer Cengiz Er
    Ahmet Muderrisoglu
    Meral Ekim
    Hasan Ekim
    Egyptian Journal of Medical Human Genetics, 23
  • [46] MTHFR C677T (rs1801133) genetic polymorphism is associated with development risk of essential hypertension in the Turkish population
    Er, Zafer Cengiz
    Muderrisoglu, Ahmet
    Ekim, Meral
    Ekim, Hasan
    EGYPTIAN JOURNAL OF MEDICAL HUMAN GENETICS, 2022, 23 (01)
  • [47] Association between methylenetetrahydrofolate reductase gene rs1801133 C/T polymorphism and urinary cancer risk
    Liu, Xing-Kai
    Zhang, Yong
    Gao, Xiao-Lin
    Zhang, Le
    Liu, Tao
    Jiang, Tai-Mao
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (05): : 7743 - 7753
  • [48] Association between MTHFR Ala222Val (rs1801133) polymorphism and bladder cancer susceptibility: a systematic review and meta-analysis
    Li, Kai
    Hu, Yong Ping
    Yang, Zecheng
    Sun, Tongxin
    TUMOR BIOLOGY, 2013, 34 (05) : 2565 - 2572
  • [49] Role of metabolizing MTHFR gene polymorphism (rs1801133) and its mRNA expression among Type 2 Diabetes
    Pathak, Divya
    Shrivastav, Dharmsheel
    Verma, Amit K.
    Alsayegh, Abdulrahman A.
    Yadav, Prasant
    Khan, Nawaid Hussain
    Al-Harbi, Alhanouf, I
    Khan, Mohammad Idreesh
    Bihade, Kapil
    Singh, Desh Deepak
    Beg, Mirza Masroor Ali
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2022, 21 (01) : 511 - 516
  • [50] Association of Methylenetetrahydrofolate Reductase rs1801133 Gene Polymorphism with Cancer Risk and Septin 9 Methylation in Patients with Colorectal Cancer
    Huang, Yafei
    Su, Ting
    Duan, Qiuting
    Wei, Xiangcong
    Fan, Xin
    Wan, Jinxiu
    Liu, Luping
    Dian, Ziqin
    Zhang, Guiqian
    Sun, Yi
    Zhou, Tao
    Xu, Ya
    JOURNAL OF GASTROINTESTINAL CANCER, 2024, 55 (02) : 778 - 786